DE HB222 | 2021-2022 | 151st General Assembly
Status
Completed Legislative Action
Spectrum: Moderate Partisan Bill (Democrat 29-5)
Status: Passed on June 30 2021 - 100% progression
Action: 2021-06-30 - Signed by Governor
Text: Latest bill text (Engrossed) [HTML]
Spectrum: Moderate Partisan Bill (Democrat 29-5)
Status: Passed on June 30 2021 - 100% progression
Action: 2021-06-30 - Signed by Governor
Text: Latest bill text (Engrossed) [HTML]
Summary
Currently, blood lead level screening and testing rates are well below what the Division of Public Health would expect them to be based on the risk factors that determine when screening or testing is necessary.
Title
An Act To Amend Title 16 And Title 18 Of The Delaware Code Relating To Childhood Lead Poisoning Prevention.
Sponsors
Roll Calls
2021-06-24 - Senate - Senate Third Reading (Y: 21 N: 0 NV: 0 Abs: 0) [PASS]
2021-06-17 - House - House Third Reading (Y: 39 N: 0 NV: 0 Abs: 2) [PASS]
2021-06-17 - House - House Third Reading (Y: 39 N: 0 NV: 0 Abs: 2) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2021-06-30 | Signed by Governor | |
| 2021-06-24 | Passed By Senate. Votes: 21 YES | |
| 2021-06-22 | Assigned to Finance Committee in Senate | |
| 2021-06-22 | Reported Out of Committee (Health & Social Services) in Senate with 5 Favorable, 1 On Its Merits | |
| 2021-06-17 | Assigned to Health & Social Services Committee in Senate | |
| 2021-06-17 | Passed By House. Votes: 39 YES 2 ABSENT | |
| 2021-06-17 | Amendment HA 1 to HB 222 - Passed In House by Voice Vote | |
| 2021-06-11 | Amendment HA 1 to HB 222 - Introduced and Placed With Bill | |
| 2021-06-09 | Reported Out of Committee (Health & Human Development) in House with 6 Favorable, 5 On Its Merits | |
| 2021-06-03 | Introduced and Assigned to Health & Human Development Committee in House |
